BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

EUR 0.06

(-4.3%)

Total Liabilities Summary of BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj's latest annual total liabilities in 2023 was 5.5 Million EUR , down -14.21% from previous year.
BBS-Bioactive Bone Substitutes Oyj's latest quarterly total liabilities in 2024 Q2 was 5.58 Million EUR , down 0.0% from previous quarter.
BBS-Bioactive Bone Substitutes Oyj reported annual total liabilities of 6.41 Million EUR in 2022, down -6.63% from previous year.
BBS-Bioactive Bone Substitutes Oyj reported annual total liabilities of 6.87 Million EUR in 2021, up 4.04% from previous year.
BBS-Bioactive Bone Substitutes Oyj reported quarterly total liabilities of 5.58 Million EUR for 2024 Q1, up 1.38% from previous quarter.
BBS-Bioactive Bone Substitutes Oyj reported quarterly total liabilities of 6.36 Million EUR for 2023 Q1, down -0.78% from previous quarter.

Annual Total Liabilities Chart of BBS-Bioactive Bone Substitutes Oyj (2023 - 2014)

Historical Annual Total Liabilities of BBS-Bioactive Bone Substitutes Oyj (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	5.5 Million EUR	-14.21%
2022	6.41 Million EUR	-6.63%
2021	6.87 Million EUR	4.04%
2020	6.6 Million EUR	-2.19%
2019	6.75 Million EUR	0.21%
2018	6.73 Million EUR	-21.63%
2017	8.6 Million EUR	4.8%
2016	8.2 Million EUR	2.7%
2015	7.99 Million EUR	9.6%
2014	7.28 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	5.58 Million EUR	0.0%
2024 Q1	5.58 Million EUR	1.38%
2023 Q1	6.36 Million EUR	-0.78%
2023 FY	5.5 Million EUR	-14.21%
2023 Q4	5.5 Million EUR	0.0%
2023 Q3	5.5 Million EUR	-13.54%
2023 Q2	6.36 Million EUR	0.0%
2022 Q2	7.14 Million EUR	0.0%
2022 Q1	7.14 Million EUR	3.93%
2022 Q4	6.41 Million EUR	0.0%
2022 FY	6.41 Million EUR	-6.63%
2022 Q3	6.41 Million EUR	-10.17%
2021 Q3	6.87 Million EUR	5.35%
2021 Q4	6.87 Million EUR	0.0%
2021 FY	6.87 Million EUR	4.04%
2021 Q1	6.52 Million EUR	-1.24%
2021 Q2	6.52 Million EUR	0.0%
2020 Q1	6.9 Million EUR	2.21%
2020 FY	6.6 Million EUR	-2.19%
2020 Q3	6.6 Million EUR	-4.31%
2020 Q4	6.6 Million EUR	0.0%
2020 Q2	6.9 Million EUR	0.0%
2019 FY	6.75 Million EUR	0.21%
2019 Q2	6.74 Million EUR	0.0%
2019 Q1	6.74 Million EUR	0.01%
2019 Q4	6.75 Million EUR	0.0%
2019 Q3	6.75 Million EUR	0.2%
2018 Q4	6.73 Million EUR	0.0%
2018 FY	6.73 Million EUR	-21.63%
2018 Q3	6.73 Million EUR	-0.22%
2018 Q2	6.75 Million EUR	0.0%
2018 Q1	6.75 Million EUR	-21.46%
2017 Q4	8.6 Million EUR	-5.83%
2017 Q1	- EUR	0.0%
2017 Q3	9.13 Million EUR	0.0%
2017 FY	8.6 Million EUR	4.8%
2016 FY	8.2 Million EUR	2.7%
2015 FY	7.99 Million EUR	9.6%
2014 FY	7.28 Million EUR	0.0%

Peer Total Liabilities Comparison of BBS-Bioactive Bone Substitutes Oyj

Name	Total Liabilities	Total Liabilities Difference
Modulight Oyj	8.23 Million EUR	33.151%
Nexstim Plc	7.04 Million EUR	21.879%
Revenio Group Oyj	37.6 Million EUR	85.359%